🇺🇸 Protein pump inhibitor. in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anaemia Of Chronic Disease — 1 report (10%)
  2. Arthropathy — 1 report (10%)
  3. Back Pain — 1 report (10%)
  4. Benign Prostatic Hyperplasia — 1 report (10%)
  5. Bk Virus Infection — 1 report (10%)
  6. Carotid Bruit — 1 report (10%)
  7. Diabetes Mellitus — 1 report (10%)
  8. Diarrhoea — 1 report (10%)
  9. Hyperlipidaemia — 1 report (10%)
  10. Hyperparathyroidism — 1 report (10%)

Source database →

Protein pump inhibitor. in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Protein pump inhibitor. approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Protein pump inhibitor. in United States?

Odense University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.